Axonics® Announces Second Quarter 2019 Financial Results and Operational Update
Axonics, Inc. (AXNX)
Last axonics, inc. earnings: 3/4 04:01 pm
Check Earnings Report
Company Research
Source: Business Wire
IRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing a novel implantable Sacral Neuromodulation (“SNM”) device for the treatment of urinary and bowel dysfunction, reported today financial results for the second quarter ended June 30, 2019, and provided an update on operational initiatives.Recent Business HighlightsNet sales of the Axonics r-SNM® System1 from international markets totaled $1.5 million in the second quarter of 2019 a sequential increase of $0.4 million in sales or approximately 38% from the 2019 first quarter. This compares to $12 thousand in revenue in the same period last year.Hiring and training of the U.S. commercial team is complete, now numbering 146 individuals, including 100 sales professionals, 11 regional sales managers and 35 clinical specialists.Commercial efforts in Europe were focused in England, the Netherlands and Germany, gaining an estimated 30%
Show less
Read more
Impact Snapshot
Event Time:
AXNX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AXNX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AXNX alerts
High impacting Axonics, Inc. news events
Weekly update
A roundup of the hottest topics
AXNX
News
- Axonics did not infringe Medtronic's patents, jury rules [Yahoo! Finance]Yahoo! Finance
- Axonics Prevails in Patent Infringement Lawsuit with Medtronic [Yahoo! Finance]Yahoo! Finance
- Axonics Prevails in Patent Infringement Lawsuit with MedtronicBusiness Wire
- Axonics gains after win in trial in patent dispute with Medtronic [Seeking Alpha]Seeking Alpha
- Axonics, Inc. (NASDAQ: AXNX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.MarketBeat
AXNX
Earnings
- 8/1/24 - Beat
AXNX
Sec Filings
- 8/1/24 - Form 10-Q
- 8/1/24 - Form 8-K
- 7/25/24 - Form 4
- AXNX's page on the SEC website